MEET THE 2026 COHORT: Radicle Science
@radiclescience is a healthtech public benefit corporation on a mission to transform mental wellness by enabling rigorous science at unprecedented speed, scale, & affordability. Since launching in 2021, Radicle Science has become the #1 U.S. generator of rigorous clinical evidence in wellness.
Through a vertically integrated, decentralized, AI-driven model, the company has conducted blinded, randomized, placebo-controlled trials with 80,000 Americans—more than all FDA drug approval trials combined over the same period. Radicle’s patent-pending Proof-as-a-Service™ platform runs end-to-end automated, gold-standard trials, creating the largest aggregated wellness clinical dataset to date, spanning biomarkers, wearables, digital health measures, behaviors, & demographics.
Radicle’s diverse community of “citizen scientists”—over 50% female, 25% racial minorities, and 20% rural participants—unlocks precision health insights across subpopulations historically invisible to science. These insights have led to multiple peer-reviewed publications with academic collaborators including Harvard, Hopkins, Yale, UCLA.
Partnering across the wellness value chain—including suppliers, manufacturers, brands, & retailers—Radicle drives treatment effectiveness, claims, & real-world impact for mental health. Led by Co-Founders,
@drjeffchen & Pelin Thorogood (
@PelinT), the 40-person strong Radicle team is redefining how non-prescription mental wellness innovations are developed, validated, & scaled for broad access.
▶︎ Learn more at
radiclescience.com
▶︎ Visit our website to learn more about the One Mind Accelerator program and this year's cohort of 14 companies shaping the future of mental health science, innovation, and treatment:
onemind.org/news/announcing-…
#2026OMA #MentalHealth #Innovation #OneMind #Accelerator #HealthTech #AI #Wellness